InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,105.16
(
1.12%
)
US TECH 100
17,240.00
(
1.54%
)
Dow Jones
38,292.53
(
0.54%
)
Brent Oil
88.20
(
0.05%
)
Bitcoin
64,004.24
(
-0.74%
)
Post# of 29253
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119493
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 14584

Wednesday, 04/05/2017 9:29:52 AM

Wednesday, April 05, 2017 9:29:52 AM

Post# of 29253
MON FY2Q17 summary: Due to a strong quarter, FY2017 non-GAAP EPS guidance is now expected to be at the high end of the previously issued $4.50-4.90 range. But this hardly matters in the short run insofar as the share price remains tied to investors' calculation of the probability that Bayer's $128/sh buyout offer will be approved by regulatory authorities.

If the Bayer deal does not go through, then MON's strong recent performance should cushion the share-price fall to some degree.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up